Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Huntington's disease

Recruiting

Investigational

Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:VOTOPLAM

Contact Research Centre

Dementia of the Alzheimer's type with delusions

Recruiting

InvestigationalNo placebo

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE

Contact Research Centre

Parkinson's disease

Recruiting

Investigational

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Dementia of the Alzheimer's type with delusions

Recruiting

Investigational

A Study of Fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Investigational

Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Investigational

Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Frontotemporal dementia

Recruiting

Registered drug

Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

Registered drug

Portugal

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:DNL593

Contact Research Centre

Psychotic disorder+1

Recruiting

Investigational

Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Psychotic disorder+1

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Parkinson's disease

Not yet recruiting

Registered drug

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Ioflupane (123I)

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Find therapies in clinical trials near you

21 trials match your criteria

Dementia Alzheimer's type

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

Huntington's disease

Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Dementia of the Alzheimer's type with delusions

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

Parkinson's disease

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Dementia of the Alzheimer's type with delusions

A Study of Fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Dementia Alzheimer's type

Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease

Dementia Alzheimer's type

Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients

Frontotemporal dementia

Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

Psychotic disorder+1

Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease

Psychotic disorder+1

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

Parkinson's disease

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Dementia Alzheimer's type

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.